The medical device industry underwent a transformation with the drug-eluting coronary stent (DES) in 2003, creating a new line of "convergence products" that held tremendous potential to open arteries...
http://www.azonano.com/article.aspx?ArticleID=3047 | 7 Jul 2012
Nanoformulation enables the sheathing of drug particles with polymeric surfactants, then layered onto a substrate for future delivery.
http://www.azonano.com/article.aspx?ArticleID=3046 | 7 Jul 2012
A number of challenges are faced by pharmaceutical companies in maintaining and developing drug therapies. Nanoformulation can help prevent loss of drug efficacy due to insolubility.
http://www.azonano.com/article.aspx?ArticleID=3045 | 7 Jul 2012
Built on a foundation of revolutionary intellectual property, Nanocopoeia has grown into a major nanotechnology player in just 10 years. With beginnings at the University of Minnesota dating back to...
Reportlinker.com announces that a new market research report is available in its catalogue: Global Coatings for Medical Devices industry...
http://www.azonano.com/news.aspx?newsID=17604 | 20 May 2010
and Markets has announced the addition of the "Drug Delivery Using
Nanotechnologies: Technologies, Markets and Competitive Environment" report
to their offering.
http://www.azonano.com/news.aspx?newsID=8440 | 31 Oct 2008
Nanocopoeia, Inc., a rapidly-growing nanotechnology company based in St. Paul, has launched its new corporate website, www.nanocopoeia.com.
The new website provides detailed information on the...
http://www.azonano.com/news.aspx?newsID=24959 | 31 May 2012
Nanocopoeia, Inc. a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products and the Saint Paul College announce the signing of an agreement for access to the...
http://www.azonano.com/news.aspx?newsID=24071 | 11 Jan 2012